These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 11017110)

  • 41. Therapeutic strategies for Huntington's disease based on a molecular understanding of the disorder.
    Haque NS; Borghesani P; Isacson O
    Mol Med Today; 1997 Apr; 3(4):175-83. PubMed ID: 9134531
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Avoiding errors in the diagnosis of (CAG)n expansion in the huntingtin gene.
    Holzmann C; Saecker AM; Epplen JT; Riess O
    J Med Genet; 1997 Mar; 34(3):264. PubMed ID: 9132504
    [No Abstract]   [Full Text] [Related]  

  • 43. Environmental enrichment rescues protein deficits in a mouse model of Huntington's disease, indicating a possible disease mechanism.
    Spires TL; Grote HE; Varshney NK; Cordery PM; van Dellen A; Blakemore C; Hannan AJ
    J Neurosci; 2004 Mar; 24(9):2270-6. PubMed ID: 14999077
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [The function of Huntington disease gene product (huntingtin) and the pathomechanism of Huntington disease].
    Nukina N
    Nihon Rinsho; 1999 Apr; 57(4):905-11. PubMed ID: 10222788
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Selective degeneration and nuclear localization of mutant huntingtin in the YAC128 mouse model of Huntington disease.
    Van Raamsdonk JM; Murphy Z; Slow EJ; Leavitt BR; Hayden MR
    Hum Mol Genet; 2005 Dec; 14(24):3823-35. PubMed ID: 16278236
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Characterising the Huntington's disease gene product.
    Wood J; MacMillan JC; Thomas P; Lowenstein PR; Harper PS; Jones AL
    Biochem Soc Trans; 1995 Nov; 23(4):595S. PubMed ID: 8654780
    [No Abstract]   [Full Text] [Related]  

  • 47. Misfolded proteins in Huntington disease fetal grafts: further evidence of cell-to-cell transfer?
    Kordower JH; Halliday G
    Ann Neurol; 2014 Jul; 76(1):20-1. PubMed ID: 24961209
    [No Abstract]   [Full Text] [Related]  

  • 48. Wild-type huntingtin participates in protein trafficking between the Golgi and the extracellular space.
    Strehlow AN; Li JZ; Myers RM
    Hum Mol Genet; 2007 Feb; 16(4):391-409. PubMed ID: 17189290
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Huntington chorea: genetics and biochemistry, diagnosis and therapy].
    Borbás T; Hegyesi H
    Acta Pharm Hung; 2002; 72(2):127-36. PubMed ID: 12498040
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Transcriptional abnormalities in Huntington disease.
    Sugars KL; Rubinsztein DC
    Trends Genet; 2003 May; 19(5):233-8. PubMed ID: 12711212
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Huntington's disease. Exploiting expression.
    Bates GP
    Nature; 2001 Oct; 413(6857):691, 693-4. PubMed ID: 11607014
    [No Abstract]   [Full Text] [Related]  

  • 52. Huntington's disease: new hope for therapeutics.
    McMurray CT
    Trends Neurosci; 2001 Nov; 24(11 Suppl):S32-8. PubMed ID: 11881743
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Editorial comment.
    Bell C
    Semin Pediatr Neurol; 2010 Mar; 17(1):49-50. PubMed ID: 20434695
    [No Abstract]   [Full Text] [Related]  

  • 54. Huntingtin aggregates ask to be eaten.
    Thoreen CC; Sabatini DM
    Nat Genet; 2004 Jun; 36(6):553-4. PubMed ID: 15167929
    [No Abstract]   [Full Text] [Related]  

  • 55. Wild-type huntingtin protects neurons from excitotoxicity.
    Leavitt BR; van Raamsdonk JM; Shehadeh J; Fernandes H; Murphy Z; Graham RK; Wellington CL; Raymond LA; Hayden MR
    J Neurochem; 2006 Feb; 96(4):1121-9. PubMed ID: 16417581
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A cellular model that recapitulates major pathogenic steps of Huntington's disease.
    Lunkes A; Mandel JL
    Hum Mol Genet; 1998 Sep; 7(9):1355-61. PubMed ID: 9700187
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Huntington's disease: from huntingtin function and dysfunction to therapeutic strategies.
    Borrell-Pagès M; Zala D; Humbert S; Saudou F
    Cell Mol Life Sci; 2006 Nov; 63(22):2642-60. PubMed ID: 17041811
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Huntington disease: advances in molecular and cell biology.
    Jones AL; Wood JD; Harper PS
    J Inherit Metab Dis; 1997 Jun; 20(2):125-38. PubMed ID: 9211185
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Phosphorylation of huntingtin reduces the accumulation of its nuclear fragments.
    Warby SC; Doty CN; Graham RK; Shively J; Singaraja RR; Hayden MR
    Mol Cell Neurosci; 2009 Feb; 40(2):121-7. PubMed ID: 18992820
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mutant huntingtin aggregates do not sensitize cells to apoptotic stressors.
    Chun W; Lesort M; Lee M; Johnson GV
    FEBS Lett; 2002 Mar; 515(1-3):61-5. PubMed ID: 11943195
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.